<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gao J</submitter><funding>NICHD NIH HHS</funding><funding>NHLBI NIH HHS</funding><pagination>188-194</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9905590</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>31(2)</volume><pubmed_abstract>Cantu Syndrome (CS), [OMIM #239850] is characterized by hypertrichosis, osteochondrodysplasia, and cardiomegaly. CS is caused by gain-of-function (GOF) variants in the KCNJ8 or ABCC9 genes that encode pore-forming Kir6.1 and regulatory SUR2 subunits of ATP-sensitive potassium (K&lt;sub>ATP&lt;/sub>) channels. Many subjects with CS also present with the complication of lymphedema. A previously uncharacterized, heterozygous ABCC9 variant, p.(Leu1055_Glu1058delinsPro), termed indel1055, was identified in an individual diagnosed with idiopathic lymphedema. The variant was introduced into the equivalent position of rat SUR2A, and inside-out patches were used to characterize the K&lt;sub>ATP&lt;/sub> channels formed by Kir6.2 and WT or mutant SUR2A subunits coexpressed in Cosm6 cells. The indel1055 variant </pubmed_abstract><journal>European journal of human genetics : EJHG</journal><pubmed_title>Lymphedema as first clinical presentation of Cantu Syndrome: reversed phenotyping after identification of gain-of-function variant in ABCC9.</pubmed_title><pmcid>PMC9905590</pmcid><funding_grant_id>R00 HL150277</funding_grant_id><funding_grant_id>R35 HL140024</funding_grant_id><funding_grant_id>K99 HL150277</funding_grant_id><funding_grant_id>R21 HD103347</funding_grant_id><pubmed_authors>McClenaghan C</pubmed_authors><pubmed_authors>van Haelst MM</pubmed_authors><pubmed_authors>Nichols CG</pubmed_authors><pubmed_authors>Christiaans I</pubmed_authors><pubmed_authors>Gao J</pubmed_authors><pubmed_authors>Alders M</pubmed_authors><pubmed_authors>van Haaften G</pubmed_authors><pubmed_authors>van Duinen K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Lymphedema as first clinical presentation of Cantu Syndrome: reversed phenotyping after identification of gain-of-function variant in ABCC9.</name><description>Cantu Syndrome (CS), [OMIM #239850] is characterized by hypertrichosis, osteochondrodysplasia, and cardiomegaly. CS is caused by gain-of-function (GOF) variants in the KCNJ8 or ABCC9 genes that encode pore-forming Kir6.1 and regulatory SUR2 subunits of ATP-sensitive potassium (K&lt;sub>ATP&lt;/sub>) channels. Many subjects with CS also present with the complication of lymphedema. A previously uncharacterized, heterozygous ABCC9 variant, p.(Leu1055_Glu1058delinsPro), termed indel1055, was identified in an individual diagnosed with idiopathic lymphedema. The variant was introduced into the equivalent position of rat SUR2A, and inside-out patches were used to characterize the K&lt;sub>ATP&lt;/sub> channels formed by Kir6.2 and WT or mutant SUR2A subunits coexpressed in Cosm6 cells. The indel1055 variant </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-04-26T11:46:31.874Z</modification><creation>2025-02-19T05:00:00.375Z</creation></dates><accession>S-EPMC9905590</accession><cross_references><pubmed>36336713</pubmed><doi>10.1038/s41431-022-01210-x</doi></cross_references></HashMap>